Jazz Pharmaceuticals plc·4

Aug 7, 6:06 PM ET

Pearce Samantha 4

4 · Jazz Pharmaceuticals plc · Filed Aug 7, 2025

Insider Transaction Report

Form 4
Period: 2025-08-05
Pearce Samantha
EVP, Chief Commercial Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2025-08-05$116.10/sh577$66,99040,815 total
Footnotes (2)
  • [F1]Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
  • [F2]The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT